DAVID
GARCIA AZORIN
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
![Foto de DAVID](/img/nophoto.png)
![Foto de Hospital Universitario de Valladolid](/img/noimage_org.png)
Hospital Universitario de Valladolid
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (141)
2024
-
Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients
Life, Vol. 14, Núm. 7
-
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
Cephalalgia : an international journal of headache, Vol. 44, Núm. 4
-
Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología
Neurologia
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Embolic Events in Infective Endocarditis: A Comprehensive Review
Reviews in Cardiovascular Medicine, Vol. 25, Núm. 3
-
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
European Journal of Neurology, Vol. 31, Núm. 5
-
Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Health equity, care access and quality in headache – part 1
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study
European Journal of Neurology, Vol. 31, Núm. 8
-
It is a long way to the top if you wanna citations?
Cephalalgia : an international journal of headache
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis
Neuroepidemiology, Vol. 58, Núm. 2, pp. 120-133
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
-
Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations
Neurological Sciences
2023
-
COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study)
Journal of Headache and Pain, Vol. 24, Núm. 1
-
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis
International Journal of Molecular Sciences, Vol. 24, Núm. 9
-
Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses
NeuroImage, Vol. 280
-
Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients
Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 35, Núm. 1, pp. 12-27
-
Corrigendum to “Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study” [Journal of the Neurological Sciences. 2023 Jun 15;449:120646] (Journal of the Neurological Sciences (2023) 449, (S0022510X23001065), (10.1016/j.jns.2023.120646))
Journal of the Neurological Sciences